All Insights

Pender Alternative Arbitrage Fund - September 2023

Dear Unitholders, Highlights The Fund initiated positions in 14 new or previously announced mergers while five merger deals held within the Fund closed during the month. At the end of September, the Fund had 41 investments in small-cap deals under $2 billion, 32 of which were valued at under $1 billion. Deal activity in Canada […]

Read More
Pender Value Fund – Q3 2023

Highlights During the quarter, we added Aecon Group Inc. (TSX:ARE) and Thinkific Labs Inc. (TSX:THNC). Canadian equities stood at 52.7% at the end of the quarter, up from 50.3% at the end of December 2022. As our Canadian exposure has grown, we have been reducing our weights to international companies, which stood at 9.5% at […]

Read More
Pender Ventures presents the first annual HealthTech Ignite Conference

Vancouver, BC, October 19, 2023 – Pender Ventures is pleased to announce their plans to host the first annual edition of HealthTech Ignite, a groundbreaking one-day conference set to take place on November 14, 2023, in the vibrant city of Montréal, Quebec. The conference aims to bring together healthcare innovators and investors with providers, payers, […]

Read More
Pender Small Cap Opportunities Fund – Q3 2023

Highlights We continue to focus on the fundamentals, rotating into high quality businesses. We initiated new positions in two companies during the quarter that we have been following for a long time but have finally hit our buy zone. Small caps are trading near trough valuations. The re-rating in multiples, we believe, is a tailwind […]

Read More
Pender Alternative Absolute Return Fund – September 2023

Highlights The primary driver of returns in September were higher interest rates, as 2024 rate cuts are being priced out in favour of a “higher for longer” for reality. The Fund continued to sell into market strength early in September before increasing exposure as markets sold off towards the end of the month. The Fund […]

Read More
Pender Corporate Bond Fund - September 2023

Highlights The Fund had several pockets of strength in September, including energy-related securities, a pharma company, and U.S.-based marijuana companies. Higher risk-free rates caused most bonds within the Fund to fall in price. We have become more constructive on longer duration issues due to a vastly improved risk/reward equation. The Pender Corporate Bond Fund returned […]

Read More
1 25 26 27 28 29 67

Sign Me Up

Receive a hand-picked selection of our latest insights monthly, straight to your inbox.

"*" indicates required fields

Email Opt In

© 2025 PenderFund Capital Management Ltd. All Rights Reserved.
crossmenuchevron-downchevron-up-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram